General Info
January Ventures is an early stage VC fund. We are replacing the friends & family round and re-writing the networks in venture.
Location: Boston
Country:
Industries:
Investment Regions:
Investment Stages: pre-seed, seed
Website: http://january.ventures/
vc
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: active
AI Reasoning: Found portfolio and announcements showing January Ventures participated in rounds during 2024 and late 2024. The Substack Year-in-Review (Dec 19, 2024) lists participation in Treefera (Series A, referenced as launched Sept 2023 but participation noted in 2024), Clarity Pediatrics (seed, participation), Oula Health (early investor; Oula raised Series B in 2024), and M7 Health (closed $4M seed Dec 2024). The most recent confirmed investment activity is December 19, 2024 (M7 Health, Clarity Pediatrics, Oula involvement noted). From that date to the evaluation date is about 10 months, which falls between 12 and 6 months. Therefore assign the corresponding tag.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of January Ventures

Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI
